levofloxacin 25 MG/ML Oral Solution

What the CMS Formulary Data Shows for levofloxacin 25 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, levofloxacin 25 MG/ML Oral Solution (RxNorm concept RXCUI 477391, generic name levofloxacin) appears on 325 distinct formulary files spanning 5,028 Medicare Part D plan offerings - 99.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.

Real-world access to levofloxacin 25 MG/ML Oral Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,827,884 Part D beneficiaries filled levofloxacin 25 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $19,171,334 and an average per-beneficiary annual cost of $10.49. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levofloxacin 25 MG/ML Oral Solution today.